USA Centers for Disease Control (CDC) news (including ME/CFS Stakeholder Engagement and Communication Calls)

What on earth did President Trump have and hold against the nurses?

Maybe he just needs more school nurses to make up the rural shortage, and any urban shortage - IF school nursing does not need the full, advanced nursing qualification. Does anyone here know?

I heard that the British government watered down nursing qualifications, some time ago, I forgot how. Few know about such thing unless in the field


Nursing Excluded as 'Professional' Degree By Department of Education

The U.S. Department of Education has officially excluded nursing in its recently revamped definition of “professional degree” programs. This change occurs as part of the implementation of President Trump’s "One Big Beautiful Bill Act" (OBBBA) and has nursing organizations nationwide raising alarms.

Key Takeaways
  • Graduate nursing students will lose access to higher federal loan limits previously available to professional degree programs.
  • Nursing students will be excluded from certain loan forgiveness programs reserved for professional degrees.
  • These changes create significant financial obstacles for students pursuing advanced nursing education.
 
U.S. Federal Register: School-Based Active Surveillance (SBAS) of ME/CFS among schoolchildren

Source: U.S. Federal Register
Vol. 91, #81, pp 22821-22822
Date: April 28, 2026
URL:
https://www.federalregister.gov/doc...rms-undergoing-paperwork-reduction-act-review

https://www.govinfo.gov/content/pkg/FR-2026-04-28/pdf/2026-08238.pdf


[A Notice by the Centers for Disease Control and Prevention]

Agency Forms Undergoing Paperwork Reduction Act Review
------------------------------------------------------

In accordance with the Paperwork Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC) has submitted the information
collection request titled 'School-Based Active Surveillance (SBAS) of
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Among Schoolchildren'
to the Office of Management and budget (OMB) for review and approval.
CDC previously published a 'Proposed Data Collection Submitted for
Public Comment and Recommendations' notice on February 11, 2026 to
obtain comments from the public and affected agencies. CDC received two
comments related to the previous notice. This notice serves to allow an
additional 30 days for public and affected agency comments.

CDC will accept all comments for this proposed information collection
project. The Office of Management and Budget is particularly interested
in comments that:

(a) Evaluate whether the proposed collection of information is necessary
for the proper performance of the functions of the agency, including
whether the information will have practical utility;

(b) Evaluate the accuracy of the agencies estimate of the burden of the
proposed collection of information, including the validity of the
methodology and assumptions used;

(c) Enhance the quality, utility, and clarity of the information to be
collected;

(d) Minimize the burden of the collection of information on those who
are to respond, including, through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submission of responses; and

(e) Assess information collection costs.

To request additional information on the proposed project or to obtain a
copy of the information collection plan and instruments, call (404)
639-7570. Comments and recommendations for the proposed information
collection should be sent within 30 days of publication of this notice
to,
http://www.reginfo.gov/public/do/PRAMain.

Find this particular information collection by selecting 'Currently
under 30-day Review-Open for Public Comments' or by using the search
function. Direct written comments and/or suggestions regarding the items
contained in this notice to the Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th Street NW, Washington, DC 20503 or by
fax to (202) 395-5806. Provide written comments within 30 days of notice
publication.


Proposed Project

School-Based Active Surveillance (SBAS) of Myalgic
Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Among Schoolchildren
(OMB Control No. 0920-1396, Exp. 4/30/2026)-Revision-National Center for
Emerging and Zoonotic Infectious Diseases (NCEZID), Centers for Disease
Control and Prevention (CDC).


Background and Brief Description

Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), a complex,
chronic, debilitating multi-system disease, affects up to 3.3 million
persons in the United States. However, about 90% of people with ME/CFS
have not received an official diagnosis from a healthcare professional.
ME/CFS affects between 0.10% and 0.75% children and adolescents, which
often goes undiagnosed by healthcare professionals.

Data on chronic conditions among schoolchildren, such as asthma, has
been collected over the years, but there has been little to no emphasis
on ME/CFS in the United States. Chronic conditions among school-aged
children likely account for a high proportion of chronic school
absenteeism and school withdrawal. Conducting active surveillance among
students using school nurses could expedite the diagnosis and management
of children who present with symptoms commonly seen in ME/CFS. This
involves educating school nurses about ME/CFS and its related syndromes,
how to best approach parents and guardians when suggesting the
diagnosis, and how to support the educational success of students with
chronic diseases. National active surveillance in schools for ME/CFS
coupled with education of school nurses about ME/CFS could help improve
measuring the burden of ME/CFS in children and provide insights for
future plans to improve healthcare in children suffering from ME/CFS and
other chronic health conditions.

In the next phase of this project, we will expand the active
surveillance project beyond the pilot schools to include additional
schools in the pilot states as well as in other states. In this national
rollout, school nurses will continue to receive education on data
collection and ME/CFs as well as technical assistance and training on
using the electronic data collection reporting platform. The SBAS
project will extend the currently approved collection to involve more
school nurses (respondents). This effort will help us to track ME/CFS
symptom burden in addition to the ME/CFS prevalence.

CDC requests OMB approval for a three-year Revision with an estimated
annual burden of 951 hours. There is no cost to respondents other than
their time to participate.

[Table removed: Estimated Annualized Burden Hours]


Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Public Health
Ethics and Regulations, Office of Science, Centers for Disease Control
and Prevention.

[FR Doc. 2026-08238 Filed 4-27-26; 8:45 am]
BILLING CODE 4163-18-P
 
Source: U.S. Federal Register
Vol. 91, #160, pp 53869-53870
Date: August 20, 2026
URL:
https://www.federalregister.gov/doc...mitted-for-public-comment-and-recommendations

https://www.govinfo.gov/content/pkg/FR-2026-08-20/pdf/2026-17040.pdf


[A Notice by the Centers for Disease Control and Prevention]

Proposed Data Collection Submitted for Public Comment and
Recommendations
-------------------------------------------------------------------------

AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).

ACTION: Notice with comment period.

SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
Federal agencies to take this opportunity to comment on a continuing
information collection, as required by the Paperwork Reduction Act of
1995. This notice invites comment on the National Health Interview
Survey (NHIS). This Extension is designed to include the continuation of
current questionnaire content and data collection operations in 2027, as
well as a systemic redesign of the NHIS to be implemented in 2028.

DATES: Written comments must be received on or before October 19, 2026.

(...)

Sponsored content from the 2026 Adult and Child Questionnaires on
chronic fatigue will remain in 2027. Sponsored content from the 2026
Adult Questionnaire on life satisfaction, diabetes, social support,
loneliness, and isolation, tobacco product use, chronic fatigue,
immunizations, whole person health, and social functioning and age of
disability onset will also remain. Sponsored content on the 2027 Adult
Questionnaire will also include questions on cancer screening,
caregiving, epilepsy, and psoriasis, similar to questions previously
fielded in 2025, and questions on occupational health, psoriasis and
Crohn's/ulcerative colitis, similar to questions fielded in 2023 and
2024.

(...)

Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Public Health
Ethics and Regulations, Office of Science, Centers for Disease Control
and Prevention.
[FR Doc. 2026-17040 Filed 8-19-26; 8:45 am]
BILLING CODE 4163-18-P

--------
 
MARK YOUR CALENDARS
September 18, 2026
3:00 pm Eastern Time


CDC ME/CFS Stakeholder Engagement and Communication (SEC) Conference Call
participants can REGISTER for the TEAMS webinar by clicking this link:
https://events.gcc.teams.microsoft.com/event/04730f5b-7739-4929-9f6b-d76de6db25a9@9ce70869-60db-44fd-abe8-d2767077fc8f?source=copyLinkLegacyShareLinkDialog

Meeting Agenda
Welcome and Meeting Overview
Updates from CDC
Joanna Regan, MD, MPH Team Lead, Clinical Research, Epidemiology, and Outreach (CREO) Team, Chronic Viral Diseases Branch, Centers for Disease Control and Prevention

“How Progress in Long COVID is helping us understand ME/CFS”
Nancy Klimas, M.D.
Professor of Medicine and Chair of the Department of Clinical Immunology; Director, Institute for Neuro-Immune Medicine (INIM), Nova Southeastern University, Davie, Florida.

Question and Answer (Q&A)

More information about CDC SEC Calls can be found at the CDC ME/CFS website.
ME/CFS Meetings | ME/CFS | CDC

Disclaimer: Although the content of calls is directed to patients, caregivers, healthcare professionals, and other interested parties, CDC has no control over who participates on the conference call. Therefore, please exercise discretion on sensitive content and material, as confidentiality during these calls cannot be guaranteed.

If you would like to be added to the call list, please send an email to CFS@cdc.gov.

Reasonable Accommodation (RA)
CDC supports participation in all events by persons with disabilities. If you require a reasonable accommodation for a disability, please contact CFS@cdc.gov as soon as possible with details of your request.
 
Last edited by a moderator:
Back
Top Bottom